We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on «Accept All», you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on «Confirm». Find detailed information and modify your preferences at any time in our Privacy Notice.
Cookies necesarias Siempre activas
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Cookies analíticas
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Comunicado por Robo de Medicamento 23 de Marzo 2025
Estimados clientes y profesionales de la salud nuestra prioridad absoluta es garantizar la calidad, eficacia y seguridad de quienes consumen...
Comunicado por Robo de Medicamento 18 de Mayo 2025
Estimados clientes y profesionales de la salud nuestra prioridad absoluta es garantizar la calidad, eficacia y seguridad de quienes consumen...
Comunicado sobre la suspensión temporal de la importación de los medicamentos Haldol...
De conformidad con la Resolución RDC n.º 18/2014, emitida por la Anvisa (Agencia Nacional de Vigilancia Sanitaria de Brasil), la...
Informe sobre transparencia y igualdad salarial entre mujeres y hombres
Notificación de cancelación del registro del medicamento Ultraproct LDO (pivalato de fluocortolona,...
De conformidad con la Resolución RDC n.º 18/2014, emitida por la Anvisa (Agencia Nacional de Vigilancia Sanitaria de Brasil), Moksha8...
Notificación de la cancelación del registro de Lisodren
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda («M8 Pharmaceuticals») anuncia que, el 7 de mayo de 2024, solicitó a...
Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Acino Publishes Second Annual Sustainability Report
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...
Acino Recognizes World Heart Day 2024
Acino reaffirms its commitment to advancing cardiovascular health in emerging markets and beyond.
Acino signs an exclusive agreement with LG Chem for Novel Treatments for...
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...